Drawing for YUNU

USPTO serial 90906481

YUNU

Reviewed by CopyMark Law Group

Reg. 7995097Status 700Registered
Filing date
Status date
Registration date
Oct 21, 2025
Examiner
RUSKIN, MATTHEW SEAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with YUNU?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Raffi Zerounian

Raffi Zerounian HANSON BRIDGETT LLP425 MARKET STREET, 26TH FLOORSAN FRANCISCO, CA 94105United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for medical imaging, conducting and managing clinical trials, conducting pharmaceutical discovery, electronic health records management, healthcare information management, analyzing medical data using artificial intelligence, picture archiving and managing communication systems, image sharing, clinical trial management, electronic data capture, medical informatics in the nature of collecting and analyzing information, and business process managementACTIVEJul 29, 2022
035Consulting services in the fields of business management of clinical trialsACTIVEJul 29, 2022
038Consulting services in the field of communications provided via electronic communication systems and image sharing in the nature of electronic transmission of imagesACTIVEJul 29, 2022
042Providing cloud-based non-downloadable software for medical imaging, conducting and managing clinical trials, conducting pharmaceutical discovery, pathology in the nature of diagnosing diseases, electronic health records management, healthcare information management, analyzing medical data using artificial intelligence, picture archiving and managing communication systems, image sharing, clinical trial management, electronic data capture, medical informatics in the nature of collecting and analyzing information, and business process management; consulting services in the fields of clinical trials for scientific research purposes, pharmaceutical discovery, artificial intelligence, electronic storage services for picture archiving, design of communication systems, providing technology for the purpose of image sharing, clinical trial project management, and electronic data captureACTIVEJul 29, 2022
044Consulting services in the fields of medical imaging, healthcare, and medical informaticsACTIVEJul 29, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 21, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 21, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 1, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 1, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 23, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 23, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 19, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2025CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 25, 2025IUAFUSE AMENDMENT FILED—
Jul 25, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 11, 2025EX5GSOU EXTENSION 5 GRANTED—
Jul 10, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 20, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 19, 2025EXT5SOU EXTENSION 5 FILED—
Aug 7, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 7, 2024EX4GSOU EXTENSION 4 GRANTED—
Aug 7, 2024EXT4SOU EXTENSION 4 FILED—
Aug 7, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 1, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 29, 2024EX3GSOU EXTENSION 3 GRANTED—
Feb 29, 2024EXT3SOU EXTENSION 3 FILED—
Feb 29, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 4, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 2, 2023EX2GSOU EXTENSION 2 GRANTED—
Aug 2, 2023EXT2SOU EXTENSION 2 FILED—
Aug 2, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 26, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 24, 2023EX1GSOU EXTENSION 1 GRANTED—
Jan 24, 2023EXT1SOU EXTENSION 1 FILED—
Jan 24, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 20, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 26, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 26, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 6, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 21, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 21, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 21, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 17, 2022ALIEASSIGNED TO LIE—
Jun 9, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2022GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 8, 2022GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 8, 2022EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Jun 8, 2022CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jun 1, 2022DOCKASSIGNED TO EXAMINER—
Sep 30, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 31, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance